Pancreatic Cancer Research

ResearcherWashington University in St. LouisActive in the last 2 years

Lauren E. Henke

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-2208-3241; OpenAlex author ID A5028872540. Sources: ClinicalTrials.gov.

Their work

Papers
10 (first author 0, last author 3)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
37
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: 3 papers, 1 trial · 2024: 2 papers · 2025: none · 2026: 2 papers

Papers 10

  1. High SMAD4 Expression is Associated With Improved Clinical Outcomes in Patients With Resectable Pancreatic Cancer: An Analysis of NRG Oncology/RTOG 9704. Co-author DOI 10.1016/j.ijrobp.2026.09.014↗
  2. Stereotactic Adaptive Radiation Therapy for Borderline Resectable or Locally Advanced Pancreatic Cancer to Minimize Gastrointestinal Toxicity (ARTIA-Pancreas):… Co-author DOI 10.2196/84607↗
  3. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label… Co-author DOI 10.1016/j.radonc.2023.110064↗
  4. Dosimetric predictors of acute and late gastrointestinal toxicities in stereotactic online adaptive magnetic resonance-guided radiotherapy (SMART) for locally … Last author DOI 10.1016/j.radonc.2024.110473↗
  5. MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A TITE-CRM Phase I Trial. Co-author DOI 10.1016/j.ijrobp.2022.07.015↗
  6. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable… Co-author DOI 10.1016/j.ijrobp.2023.05.023↗
  7. Knowledge-based adaptive planning quality assurance using dosimetric indicators for stereotactic adaptive radiotherapy for pancreatic cancer. Co-author DOI 10.1016/j.radonc.2023.109603↗
  8. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer. Last author DOI 10.1016/j.radonc.2022.08.026↗
  9. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR). Last author DOI 10.1186/s13014-022-02125-z↗
  10. Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation. Co-author DOI 10.1016/j.adro.2020.06.010↗

Trials 1

  1. Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach Principal investigator NCT05764720↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hyun Jee Kim · 9 shared papers, 2021–2026 · strength 1.47
  2. Alex T. Price · 6 shared papers, 2022–2026 · strength 1.03
  3. Shahed Nicolas Badiyan · 5 shared papers, 2022–2024 · strength 0.78
  4. Joshua P. Schiff · 4 shared papers, 2022–2024 · strength 0.64
  5. Clifford Grant Robinson · 3 shared papers, 2022–2024 · strength 0.48
  6. Parag Jitendra Parikh · 3 shared papers, 2023–2024 · strength 0.41
  7. Michael Frederick Bassetti · 2 shared papers, 2023–2024 · strength 0.27
  8. Michael David Chuong · 2 shared papers, 2023–2024 · strength 0.27
  9. John Ng · 2 shared papers, 2023–2024 · strength 0.27
  10. Luca Boldrini · 2 shared papers, 2023–2024 · strength 0.27
  11. Kathryn Elizabeth Mittauer · 2 shared papers, 2023–2024 · strength 0.27
  12. Lorenzo Placidi · 2 shared papers, 2023–2024 · strength 0.27
  13. Adam Christopher Mueller · 2 shared papers, 2023–2024 · strength 0.27
  14. Lorraine Portelance · 2 shared papers, 2023–2024 · strength 0.27
  15. Bassem I. Zaki · 2 shared papers, 2023–2024 · strength 0.27
  16. Joseph Douglas Mancias · 2 shared papers, 2023–2024 · strength 0.27
  17. Percy P. Lee · 2 shared papers, 2023–2024 · strength 0.27
  18. Daniel A. Low · 2 shared papers, 2023–2024 · strength 0.27
  19. William G. Hawkins · 2 shared papers, 2021–2023 · strength 0.26
  20. Ryan C Fields · 2 shared papers, 2021–2023 · strength 0.26
  21. Andrea Wang‐Gillam · 2 shared papers, 2021–2023 · strength 0.26
  22. Hyun Kim · 1 shared paper, 2026 · strength 0.24
  23. Chandan Guha · 1 shared paper, 2026 · strength 0.24
  24. William F. Regine · 1 shared paper, 2026 · strength 0.24
  25. Edgar Ben‐Josef · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.